Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
see.ip - Details for AUF CD47 GERICHTETE THERAPIEN ZUR BEHANDLUNG VON INFEKTIONSKRANKHEITEN
Details for 2022185801
Up to date per 13.06.2026
Actions
Details for 2022185801
Title / Product Name
AUF CD47 GERICHTETE THERAPIEN ZUR BEHANDLUNG VON INFEKTIONSKRANKHEITEN
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2022185801
EP Publication Number
4119153
E-Number
1678879
Language
EN
PCT Number
Publication Date
18.01.2023 A
24.04.2024 B1
Registration Date
24.04.2024
AT Publication Date
15.05.2024
Application Date
05.02.2014
Registration Number
-
Priorities
05.02.2013
US
201361761133 P
IPC
A61K 38/17 20060101AFI20221123BHEP
Maximum Duration of Protection
05.02.2034
Owner
The Board of Trustees of the Leland Stanford Junior UniversityOffice of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386 Stanford, CA 94305-2038US
The United States of America, as represented by the Secretary, Department of Health and Human Services6011 Executive Boulevard, Suite 325, MSC 7660 Bethesda, MD 20892-7660US
The Regents of the University of California1111 Franklin Street, 12th Floor Oakland, CA 94607-5200US